230 related articles for article (PubMed ID: 17510806)
1. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
[TBL] [Abstract][Full Text] [Related]
2. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
[TBL] [Abstract][Full Text] [Related]
3. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
5. An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil- or oleic acid-enriched diets in mice with experimental colitis.
Ramakers JD; Mensink RP; Verstege MI; te Velde AA; Plat J
Br J Nutr; 2008 Aug; 100(2):347-54. PubMed ID: 18205994
[TBL] [Abstract][Full Text] [Related]
6. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
[TBL] [Abstract][Full Text] [Related]
8. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the anti-inflammatory and therapeutic actions of PPAR-gamma agonists rosiglitazone and troglitazone in experimental colitis.
Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Slomka M
J Physiol Pharmacol; 2012 Dec; 63(6):631-40. PubMed ID: 23388479
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
[TBL] [Abstract][Full Text] [Related]
12. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
13. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
14. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
16. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
Martín AR; Villegas I; Alarcón de la Lastra C
Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
[TBL] [Abstract][Full Text] [Related]
18. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.
Katada K; Yoshida N; Suzuki T; Okuda T; Mizushima K; Takagi T; Ichikawa H; Naito Y; Cepinskas G; Yoshikawa T
Inflamm Res; 2008 Feb; 57(2):84-91. PubMed ID: 18288458
[TBL] [Abstract][Full Text] [Related]
19. Attenuation by dietary taurine of dextran sulfate sodium-induced colitis in mice and of THP-1-induced damage to intestinal Caco-2 cell monolayers.
Zhao Z; Satsu H; Fujisawa M; Hori M; Ishimoto Y; Totsuka M; Nambu A; Kakuta S; Ozaki H; Shimizu M
Amino Acids; 2008 Jun; 35(1):217-24. PubMed ID: 17619120
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]